Relative Bioavailability of Two Tepotinib Film-Coated Tablet Formulations in Healthy Volunteers
Clinical trial NCT03021642 · COMPLETED
Trial details
- NCT number
- NCT03021642
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-31
- Primary completion
- 2016-03-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.